NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
Income statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $2.9B | $2.4B | $1.9B | $1.5B | $1.1B | $1.0B | $788M | $451M | $162M | $15M | $20M | $0 | $2.9M | $53M | $77M | $34M | $3.0M |
| R&D | $1.1B | $1.0B | $731M | $565M | $464M | $328M | $275M | — | $161M | $122M | $94M | $81M | $46M | $39M | $37M | $31M | $31M | $34M |
| SG&A | $1.4B | $1.2B | $1.0B | $888M | $753M | $583M | $433M | $354M | $249M | $170M | $68M | $32M | — | — | — | — | — | — |
| Operating income | $795M | $619M | $571M | $251M | $249M | $103M | $163M | $72M | $37M | −$131M | −$147M | −$94M | −$64M | −$50M | $1.4M | $34M | −$14M | −$54M |
| Non-operating income | $145M | $86M | −$85M | $81M | −$35M | −$1.1M | −$56M | −$26M | −$15M | −$11M | $6.3M | — | — | — | — | — | — | — |
| Pretax income | $940M | $705M | $486M | $332M | $214M | $101M | $107M | $47M | $22M | −$143M | −$141M | — | — | — | — | — | — | — |
| Taxes | $235M | $227M | $145M | $82M | $59M | $12M | −$301M | $9.5M | $700K | $0 | $0 | — | — | — | — | — | — | — |
| Net income | $706M | $479M | $341M | $250M | $155M | $90M | $407M | $37M | $21M | −$143M | −$141M | −$89M | −$61M | −$46M | $5.0M | $38M | −$8.0M | −$51M |
| Diluted EPS | $6.82 | $4.67 | $3.29 | $2.47 | $1.56 | $0.92 | $4.16 | $0.39 | $0.22 | −$1.62 | −$1.63 | −$1.05 | −$0.81 | −$0.69 | $0.08 | $0.67 | −$0.15 | −$1.30 |
| Diluted shares | — | 102.5M | 103.7M | 101.0M | 98.9M | 97.9M | 97.8M | 95.7M | 95.4M | 88.1M | 86.7M | 84.5M | 74.6M | 67.0M | 66.9M | 56.3M | 52.8M | 39.1M |
| Revenue growth | — | +21.4% | +24.8% | +26.8% | +31.3% | +8.4% | +32.7% | +74.7% | +179.2% | +977.5% | −24.1% | — | −100.0% | −94.5% | −31.4% | +131.1% | +1,034.5% | — |
| Operating margin | 23.6% | 21.6% | 24.2% | 13.3% | 16.7% | 9.0% | 15.6% | 9.2% | 8.2% | −81.3% | −982.5% | −476.5% | — | −1,701.9% | 2.7% | 43.8% | −41.0% | −1,817.5% |
| Net margin | 20.9% | 16.7% | 14.5% | 13.2% | 10.4% | 7.9% | 38.9% | 4.7% | 4.7% | −88.2% | −940.6% | −449.8% | — | −1,579.0% | 9.5% | 48.5% | −23.8% | −1,728.3% |